Meeting
2023 ASCO Annual Meeting
Prospective evaluation of the utility of concurrent 18F-FDG PET/CT and 68Ga-DOTA-TOC imaging in gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): The PETNET study.
Authors
Joao Paulo Solar Vasconcelos
BC Cancer, Vancouver Cancer Centre, Vancouver, BC, Canada
Joao Paulo Solar Vasconcelos , Marilyn Zhou , Pavithraa Ravi , Hayley Allan , Heather Saprunoff , Ingrid Bloise , Sara Harsini , Don Wilson , Francois Benard , Patrick Martineau , Jonathan M. Loree
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Neuroendocrine/Carcinoid
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4022)
DOI
10.1200/JCO.2023.41.16_suppl.4022
Abstract #
4022
Poster Bd #
343
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
18F-Fluoroestradiol (FES) and 18F-Fluorodeoxyglucose (FDG) PET imaging in lobular breast cancer.
First Author: Poorni Manohar
Poster
2018 Gastrointestinal Cancers Symposium
Survival for small, well-differentiated PNETs in relation to treatment.
First Author: bao-Quynh Julian
Poster
2017 ASCO Annual Meeting
The use of 18F-fluoroestradiol (FES) and 18F-fluorodeoxyglucose (FDG) PET in the evaluation of breast cancer heterogeneity.
First Author: Lanell M Peterson
Poster
2024 ASCO Genitourinary Cancers Symposium
PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort.
First Author: Mathilde Cancel